Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Abemaciclib + Letrozole for Endometrial Cancer
Recruiting1 awardPhase 2
Greenwich, Connecticut
This trial is testing a new cancer drug to see if it stops the disease from progressing in women with endometrioid endometrial cancer. Treatment will continue until the patient experiences side effects, the disease progresses, or they request to stop.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service